tirzepatide and svt Cardiovascular outcomes of semaglutide for patients with type 2 diabetes in clinical practice Tirzepatide (Zepbound)
Description
Received: Accepted: Published: Version of record: Issue date: DOI:
Be aware that dose changes, including increases, are the most common trigger for this side effect
While rare, its serious and if you experience these symptoms, seek medical care immediately
Castellani LN, Costa-Dookhan KA, McIntyre WB, Wright DC, Flowers SA, Hahn MK, et al
